Effect of Porphyromonas gingivalis infection on post-transcriptional regulation of the low-density lipoprotein receptor in mice

Lipids in Health and Disease

Volumn 11, Issue , 2012, Pages

  Miyazawa, Haruna ^a,b   Tabeta, Koichi ^a   Miyauchi, Sayuri ^a,b   Aoki Nonaka, Yukari ^a,b   Domon, Hisanori ^a   Honda, Tomoyuki ^a,b   Nakajima, Takako ^a,c   Yamazaki, Kazuhisa ^a,b  

^a NIIGATA UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

Chronic inflammation; LDL cholesterol; PCSK9; Periodontitis

Indexed keywords

LIVER X RECEPTOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9; SERINE PROTEINASE; SERUM AMYLOID A; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE; GENE EXPRESSION; INFECTION; LOW DENSITY LIPOPROTEIN RECEPTOR GENE; MALE; MOUSE; NONHUMAN; PORPHYROMONAS GINGIVALIS; PORPHYROMONAS GINGIVALIS INFECTION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STEROL REGULATORY ELEMENT BINDING PROTEIN 2 GENE; UPREGULATION;

ANIMALS; BACTEROIDACEAE INFECTIONS; CHOLESTEROL; CHOLESTEROL, LDL; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HUMANS; LIPIDS; LIVER; MALE; MICE; MICE, INBRED C57BL; ORPHAN NUCLEAR RECEPTORS; PORPHYROMONAS GINGIVALIS; PROPROTEIN CONVERTASES; RECEPTORS, LDL; RNA PROCESSING, POST-TRANSCRIPTIONAL; SERINE ENDOPEPTIDASES; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS; PORPHYROMONAS GINGIVALIS;

EID: 84866274478     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-11-121     Document Type: Article

References (21)

1. Association between periodontal pockets and elevated cholesterol and low density lipoprotein cholesterol levels. Katz J, Flugelman MY, Goldberg A, Heft M, J Periodontol 2002 73 494 500 10.1902/jop.2002.73.5.494 12027250 (Pubitemid 34546399)
2. Plasma lipid and blood glucose levels in patients with destructive periodontal disease. Losche W, Karapetow F, Pohl A, Pohl C, Kocher T, J Clin Periodontol 2000 27 537 541 10.1034/j.1600-051x.2000.027008537.x 10959778
3. Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. D'Aiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS, J Dent Res 2005 84 269 273 10.1177/154405910508400312 15723869 (Pubitemid 43822036)
4. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, Hua X, Goldstein JL, Brown MS, Cell 1993 75 187 197 8402897 (Pubitemid 23306032)
5. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Zelcer N, Hong C, Boyadjian R, Tontonoz P, Science 2009 325 100 104 10.1126/science.1168974 19520913
6. Molecular basis of PCSK9 function. Lambert G, Charlton F, Rye KA, Piper DE, Atherosclerosis 2009 203 1 7 10.1016/j.atherosclerosis.2008.06.010 18649882
7. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation. Seidah NG, Benjannet S, Wickham L, Marcinkiewicz J, Jasmin SB, Stifani S, Basak A, Prat A, Chretien M, Proc Natl Acad Sci US A 2003 100 928 933 10.1073/pnas.0335507100 (Pubitemid 36183932)
8. Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation. Zhang DW, Lagace TA, Garuti R, Zhao Z, McDonald M, Horton JD, Cohen JC, Hobbs HH, J Biol Chem 2007 282 18602 18612 10.1074/jbc.M702027200 17452316 (Pubitemid 47100234)
9. Increased serum PCSK9 concentrations are associated with periodontal infection but do not correlate with LDL cholesterol concentration. Miyazawa H, Honda T, Miyauchi S, Domon H, Okui T, Nakajima T, Tabeta K, Yamazaki K, Clin Chim Acta 2012 413 154 159 10.1016/j.cca.2011.09.023 22001517
10. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C, J Lipid Res 2004 45 1169 1196 10.1194/jlr.R300019-JLR200 15102878 (Pubitemid 38802622)
11. Inflammation stimulates the expression of PCSK9. Feingold KR, Moser AH, Shigenaga JK, Patzek SM, Grunfeld C, Biochem BiophysRes Commun 2008 374 341 344 10.1016/j.bbrc.2008.07.023
12. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Cohen J, Pertsemlidis A, Kotowski IK, Graham R, Garcia CK, Hobbs HH, Nat Genet 2005 37 161 165 10.1038/ng1509 15654334
13. Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9. Rashid S, Curtis DE, Garuti R, Anderson NN, Bashmakov Y, Ho YK, Hammer RE, Moon YA, Horton JD, Proc Natl Acad Sci U S A 2005 102 5374 5379 10.1073/pnas.0501652102 15805190 (Pubitemid 40530265)
14. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Abifadel M, Varret M, Rabes JP, Allard D, Ouguerram K, Devillers M, Cruaud C, Benjannet S, Wickham L, Erlich D, et al. Nat Genet 2003 34 154 156 10.1038/ng1161 12730697 (Pubitemid 36666925)
15. PCSK9: a promising therapeutic target for dyslipidemias? Lambert G, Krempf M, Costet P, Trends Endocrinol Metab 2006 17 79 81 10.1016/j.tem.2006.02. 001 16487721
16. Chronic Oral Infection with Porphyromonas gingivalis accelerates atheroma formation by shifting the lipid profile. Maekawa T, Takahashi N, Tabeta K, Aoki Y, Miyashita H, Miyauchi S, Miyazawa H, Nakajima T, Yamazaki K, PLoS ONE 2011 6 20240 10.1371/journal.pone.0020240 21625524
17. Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia. Dubuc G, Chamberland A, Wassef H, Davignon J, Seidah NG, Bernier L, Prat A, Arterioscler Thromb Vasc Biol 2004 24 1454 1459 10.1161/01.ATV.0000134621.14315.43 15178557 (Pubitemid 39050440)
18. Sterol-dependent regulation of proprotein convertase subtilisin/kexin type 9 expression by sterol-regulatory element binding protein-2. Jeong HJ, Lee HS, Kim KS, Kim YK, Yoon D, Park SW, J Lipid Res 2008 49 399 409 17921436 (Pubitemid 351213625)
19. Hepatocyte nuclear factor 1alpha plays a critical role in PCSK9 gene transcription and regulation by the natural hypocholesterolemic compound berberine. Li H, Dong B, Park SW, Lee HS, Chen W, Liu J, J Biol Chem 2009 284 28885 28895 10.1074/jbc.M109.052407 19687008
20. Novel domain interaction regulates secretion of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein. Du F, Hui Y, Zhang M, Linton MF, Fazio S, Fan D, J Biol Chem 2011 286 43054 43061 10.1074/jbc.M111.273474 22027821
21. Post-transcriptional regulation of lipoprotein receptors by the E3-ubiquitin ligase inducible degrader of the low-density lipoprotein receptor. Sorrentino V, Zelcer N, Curr Opin Lipidol 2012 23 3 213 219 10.1097/MOL. 0b013e3283532947 22510808